NuVasive celebrated its one-year anniversary of opening an office in Tokyo, the company's first office in Japan.
NuVasive received regulatory Shonin approval for products supportive of the eXtreme Lateral Interbody Fusion surgical procedure in April 2013 and trained many surgeons in the procedure. The company also reported case volume growth with the Precept, Armada and Co-Roent systems and implants.
More Articles on Spine Devices:
20 Spine Devices Receive FDA 510(k) Clearance in March
LDR Announces Follow-On Public Offering
VertiFlex Submits Final PMA Module for FDA for Superion Interspinous Spacer